Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed flat MA payment rates for 2027.

Clover Health Investments is now a contrarian buy, with the market underestimating its path to profitability in 2026. See why I rate the CLOV stock a Buy.

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Detailed price information for Clover Health Investments Corp (CLOV-Q) from The Globe and Mail including charting and trades.

Clover Health Investments, Corp. announced that Lee A. Shapiro, a member of its Board of Directors, will not seek reelection after serving for four years due to his new role as Chairman of the ...

Fourth Quarter and Full Year 2025 Conference Webcast Details: What : Clover Health’s Fourth Quarter and Full Year 2025 Earnings Conference Call A live and archived webcast of the conference call will ...

Clover Health Investments Corp (NASDAQ:CLOV) saw its shares jump more than 12.54% to $3.77 on Wednesday by market close, following better-than-expected profitability in the first quarter, despite ...

Clover Health's unique Medicare PPO plans target underserved rural populations, offering in-home services and modern technology for effective health management. Despite a leading benefit expense ratio ...

Over the last six months, Clover Health’s shares have sunk to $2.60, producing a disappointing 13.5% loss - a stark contrast ...

Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how health insurance providers stocks fared in Q3, starting with ...